Sundaram Multi Pap Ltd Falls to 52-Week Low of Rs.1.57 Amid Continued Downtrend

3 hours ago
share
Share Via
Sundaram Multi Pap Ltd’s shares declined to a fresh 52-week low of Rs.1.57 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance issues.
Sundaram Multi Pap Ltd Falls to 52-Week Low of Rs.1.57 Amid Continued Downtrend



Stock Price Movement and Market Context


The stock has been on a downward trajectory for the past three trading sessions, cumulatively losing 6.15% over this period. Today’s fall of 1.18% further extended this decline, underperforming its sector by 1.13%. Sundaram Multi Pap Ltd is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.


In contrast, the broader market index, Sensex, opened flat but closed lower by 246.25 points or 0.34% at 82,961.13, remaining 3.85% shy of its 52-week high of 86,159.02. The Sensex itself has been on a three-week losing streak, down 3.27% over this span, and is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating mixed medium-term market signals.



Financial Performance and Valuation Concerns


Sundaram Multi Pap Ltd’s one-year stock performance has been notably weak, with a decline of 28.51%, starkly contrasting with the Sensex’s positive return of 7.64% over the same period. The stock’s 52-week high was Rs.2.41, highlighting the extent of the recent price erosion.


The company’s fundamental metrics have contributed to the subdued investor sentiment. Its long-term return on capital employed (ROCE) averages a modest 1.94%, reflecting limited efficiency in generating returns from capital investments. Operating profit growth has been sluggish, with a compound annual growth rate of just 2.88% over the last five years.


Debt servicing capacity remains a concern, as evidenced by a poor average EBIT to interest coverage ratio of 0.16, indicating that earnings before interest and tax are insufficient to comfortably cover interest expenses. This weak coverage ratio suggests heightened financial risk and potential strain on cash flows.




Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!



  • - Just announced pick

  • - Pre-market insights shared

  • - Tyres & Allied weekly focus


Get Pre-Market Insights →




Profitability and Risk Profile


The company’s profitability has deteriorated significantly over the past year, with profits falling by 137.1%. This sharp contraction in earnings has contributed to the stock’s classification as a strong sell, reflected in its Mojo Score of 17.0 and a recent downgrade from Sell to Strong Sell on 21 Oct 2024. The Market Cap Grade stands at 4, indicating a relatively small market capitalisation and associated liquidity considerations.


Over the last three years, Sundaram Multi Pap Ltd has consistently underperformed the BSE500 benchmark, reinforcing concerns about its growth trajectory and market competitiveness. The stock’s risk profile is elevated due to its negative operating profits and valuation levels that are considered risky relative to historical averages.



Quarterly Performance Highlights


Despite the overall challenging environment, the company reported some positive quarterly results in September 2025. The Profit Before Depreciation, Interest and Tax (PBDIT) reached a quarterly high of Rs.1.74 crore, while the operating profit to net sales ratio peaked at 6.68%. Additionally, Profit Before Tax excluding other income (PBT less OI) was recorded at Rs.0.79 crore, the highest in recent quarters. These figures indicate pockets of operational strength amid broader financial pressures.


The majority shareholding remains with non-institutional investors, which may influence trading patterns and liquidity dynamics.




Considering Sundaram Multi Pap Ltd? Wait! SwitchER has found potentially better options in Miscellaneous and beyond. Compare this micro-cap with top-rated alternatives now!



  • - Better options discovered

  • - Miscellaneous + beyond scope

  • - Top-rated alternatives ready


Compare & Switch Now →




Summary of Key Metrics


The stock’s recent performance and fundamental indicators paint a picture of sustained pressure. Key metrics include:



  • Current price at 52-week low: Rs.1.57

  • One-year return: -28.51%

  • Mojo Score: 17.0 (Strong Sell)

  • ROCE (5-year average): 1.94%

  • Operating profit growth (CAGR 5 years): 2.88%

  • EBIT to Interest coverage ratio: 0.16

  • Profit decline over past year: -137.1%

  • Market Cap Grade: 4


These figures underscore the challenges faced by Sundaram Multi Pap Ltd in maintaining profitability and growth momentum within the miscellaneous sector.



Broader Market and Sector Comparison


While the Sensex has experienced a modest decline recently, it remains significantly above its lows and continues to trade near its 52-week high. Sundaram Multi Pap Ltd’s underperformance relative to both the Sensex and its sector peers highlights the divergence in investor sentiment and company-specific factors affecting its valuation.


The stock’s position below all major moving averages contrasts with the broader market’s mixed technical signals, emphasising the stock’s current weakness within the miscellaneous sector.



Shareholding and Liquidity Considerations


The predominance of non-institutional shareholders may contribute to lower trading volumes and increased volatility. This shareholder composition can affect price stability and the stock’s responsiveness to market developments.



Conclusion


Sundaram Multi Pap Ltd’s decline to a 52-week low of Rs.1.57 reflects a combination of subdued financial performance, weak profitability metrics, and challenging market conditions. The stock’s downgrade to a Strong Sell rating and its low Mojo Score further illustrate the cautious stance adopted by rating agencies. While the company has demonstrated some positive quarterly results, these have not yet translated into sustained improvement in its overall financial health or stock performance.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 19 2026 10:10 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 06 2026 10:11 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Dec 25 2025 03:12 PM IST
share
Share Via
Why is Sundaram Multi. falling/rising?
Dec 09 2025 12:29 AM IST
share
Share Via